Sarcoma, Soft Tissue: Clinical Trials

2 trials for Sarcoma, Soft Tissue, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2

Follow Sarcoma, Soft Tissue: new trials by email Literature Review of Sarcoma, Soft Tissue trials Research Report on Sarcoma, Soft Tissue

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma
Nintedanib, Ifosfamide - Sarcoma, Soft Tissue
Phase 2TerminatedEuropean Organisation for Research and Treatment of Cancer - EORTC802017-07-072021-09-20
Sunitinib in Certain Subtypes of Soft Tissue Sarcomas
Sunitinib - Sarcoma, Soft Tissue
Phase 2TerminatedColumbia University102007-04-012019-11-04

Narrower conditions

Sarcoma (2)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Connective and Soft Tissue (2)

Interventions

Ifosfamide (1)  ·  Sunitinib (1)  ·  nintedanib (1)

Sponsors

Columbia University (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)

Countries

Belgium (1)  ·  France (1)  ·  Lithuania (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Patrick Schoeffski, MD (1)  ·  Robert N Taub, MD, PhD (1)

Results publications

PMID 34062484

NIH funding

2016 (1)